APCs – How much should they cost?

DOI: https://doi.org/10.7557/5.4830
Keywords: APCs, Article Processing Charges, Open Access, transparency

Abstract

Gold Open Access can be facilitated by an Article Processing Charge (APC), which refers to the author-facing charge levied for publishing an article openly in a specific journal. These charges vary significantly across journals and recently there has been a demand for publishers to be more transparent about how their APCs are calculated. Plan S has clearly set the need for transparency in its principles and implementations stating “When Open Access publication fees are applied, they must be commensurate with the publication services delivered and the structure of such fees must be transparent to inform the market and funders potential standardisation and capping of payments of fees”. This presentation will provide a landscape analysis of publishers, new initiatives (such as the new work just commissioned by the Wellcome and UKRI on behalf of cOAlition S on providing a framework to enable more transparent communication of OA publishing services and prices; http://www.informationpower.co.uk/news/press-release-transparent-comms-of-oa-services-and-prices/) and the current transparency around APCs and explore the range of direct and indirect costs of what constitutes an APC.

Author Biography

Michael Markie, F1000

Michael Markie is the Publishing Director for F1000 Platforms. He is an open science, open data and open research advocate leading F1000’s effort to change the way science is communicated. He played a pivotal role in devising the open research publishing model and launching F1000Research in 2013, and now oversees the  development of the publishing platform services F1000 provide for leading funders and institutions such Wellcome and Bill and Melinda Gates Foundation. Michael is an active member of the open science community and gives many talks/seminars/workshops on the subject at international conferences and research institutions. Michael previously studied Chemical Biology at the University of Leeds, where he worked on synthesising a range of potential anti-tumour compounds.

Published
2019-09-20
Issue
No 1 (2019): The 14th Munin Conference on Scholarly Publishing 2019
Section
Presentations

Copyright (c) 2019 Michael Markie

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  • Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).